Zacks Investment Research on MSN
CVRx stock up on Humana's Medicare coverage for Barostim therapy
CVRx Inc. CVRX announced a key reimbursement win after Humana issued a Medicare Advantage coverage policy for its Barostim ...
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced that it has received commercial insurance coverage for its Prospera Heart ...
Healthcare providers, suppliers, compliance leaders, and private equity-backed platforms may prepare for increasing operational, ...
– New Additions to Medicare Formularies at Optum/United AARP and CVS/SilverScript Coupled with Humana Provides Access to More Than 65% of Medicare Insured Lives and More Than 92% of Commercially ...
(NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular ...
The lack of commercial coverage for digitally enabled care is a roadblock to affordable access to these medical services, according to the American Medical Association. The model of integrating ...
Cigna Expands Commercial and Medicare AdvantageCoverage to Include Mdxhealth’s Select mdx for Prostate Cancer Test Expansion of coverage with Cigna now includes full menu of Company’s precision ...
Millions of older Americans may have access for the first time to obesity drugs at a low price of $50 a month starting in ...
When people choose an MA plan, they count on it to provide the agreed-upon coverage for current medical needs and those that ...
An analysis of two markets shows some commercial plans provide the lowest estimated yearly costs, but federal annuitants must consider the required trade-offs like prior authorization and provider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results